Clinicopathological Features Predict Outcomes in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Real-World Study

JOURNAL ARTICLE published 1 April 2020 in The Oncologist

Research funded by Shanghai Key Discipline of Medical Imaging (2017ZZ02005) | National Natural Science Foundation of China (81671711)

Authors: Lin Cheng | Hao Fu | Yuchen Jin | Ri Sa | Libo Chen